artículo académico

• Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Tria.  Journal of the National Cancer Institute.  112:1030-1037. 2020
• Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.  Journal of Infectious Diseases.  2020
• Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.  Journal of the National Cancer Institute.  112:818-828. 2020
• Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  112:1038-1046. 2020
• Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.  Vaccine.  38:5997-6006. 2020
• Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes .  The Journal of Infectious Diseases.  220:1609-1619. 2019
• Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.  Contemporary Clinical Trials.  68:35-44. 2018
• Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  110:205-212. 2018
• Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies.  Vaccine.  36:4774-4782. 2018
• T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.  PLoS ONE.  13. 2018
• Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18‐Year follow‐up of the Guanacaste cohort.  International Journal of Cancer.  140:1926-1934. 2017
• Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.  Journal of Proteomics.  150:201-215. 2017
• The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.  Sexually Transmitted Diseases.  44:442-449. 2017
• Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.  American Journal of Obstetrics and Gynecology.  215:212.e1-212.e15. 2016
• Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage.  Helicobacter.  21:325-333. 2016
• Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.  Journal of Infectious Diseases.  213:939-947. 2015
• Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.  BMJ Journal.  351. 2015
• Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials.  The Lancet Oncology.  16:775-786. 2015
• Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.  Journal of the National Cancer Institute.  108. 2015
• Performance of Self-Collected Cervical Samples in Screening for Future Precancer Using Human Papillomavirus DNA Testing.  Journal of the National Cancer Institute.  107. 2015
• Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.  The Lancet Oncology.  16:e226-e233. 2015
• Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.  Vaccine.  33:2141-2151. 2015
• Wood physical properties, color, decay resistance and stiffness in Tectona grandis clones with evidence of genetic control.  Silvae Genetica.  62:142-152. 2013
• Sekikaic Acid and Lobaric Acid Target a Dynamic Interface of the Coactivator CBP/p300.  Angewandte Chemie-International Edition.  51:11258-11262. 2012
• Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years.  Cancer Epidemiology Biomarkers & Prevention.  19:3044-3054. 2010
• Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles.  Cancer Epidemiology Biomarkers & Prevention.  19:978-981. 2010
• Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection.  Cancer Epidemiology Biomarkers & Prevention.  19:1954-1959. 2010
• Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients.  The Journal of Immunology.  182:1706-1729. 2009
• Cytokine and Chemokine Profiles following Vaccination with Human Papillomavirus Type 16 L1 Virus-Like Particles.  Clinical and Vaccine Immunology.  14:984-989. 2007
• DNAse treatment following thawing of Cryopreserved PBMC is a procedure suitable for lymphocyte functional studies.  Journal of Immunological Methods.  313:209-213. 2006
• Discussions of ODP leg 205 and drilling of Middle America Seismogenic Zone.  Eos, Transactions, American Geophysical Union .  36:437-445. 2006
• Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women.  Cancer Research .  66:11070-11076. 2006